Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery.
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2012
At a glance
- Drugs Dexamethasone (Primary) ; Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 02 Feb 2012 Actual patient number changed from 100 to 94 as reported by ClinicalTrials.gov.
- 19 Nov 2009 New trial record